42 Results for "

palbociclib

" in MedChemExpress (MCE) Product Catalog:
Products (42)

42 Results for "palbociclib" in MCE Product Catalog:

249
249 Publications Verification
Art. -Nr.: HY-50767
CAS. Nr.: 571190-30-2
Synonyms: PD 0332991
Target:  

CDK

Forschungsgebiete:  

Cancer

Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
249
249 Publications Verification
Art. -Nr.: HY-50767A
CAS. Nr.: 827022-32-2
Synonyms: PD 0332991 monohydrochloride
Target:  

CDK

Forschungsgebiete:  

Cancer

Palbociclib (PD 0332991) monohydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib monohydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
245
245 Cited Publications
Art. -Nr.: HY-A0065
CAS. Nr.: 827022-33-3
Synonyms: PD 0332991 isethionate
Target:  

CDK

Forschungsgebiete:  

Infection Neurological Disease Cancer

Palbociclib (PD 0332991) isethionate is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib isethionate has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
229
229 Cited Publications
Art. -Nr.: HY-50767C
CAS. Nr.: 571189-11-2
Synonyms: PD-0332991 hydrochloride
Target:  

CDK

Forschungsgebiete:  

Cancer

Palbociclib (PD 0332991) hydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib hydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells. Palbociclib hydrochloride can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
91
91 Cited Publications
Art. -Nr.: HY-14275
CAS. Nr.: 52-53-9
Reinheit:  98.96%
Synonyms: (±)-Verapamil; CP-16533-1
Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research .
loading...
    loading...
91
91 Cited Publications
Art. -Nr.: HY-A0064
CAS. Nr.: 152-11-4
Synonyms: (±)-Verapamil hydrochloride; CP-16533-1 hydrochloride
Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil hydrochloride also inhibits CYP3A4. Verapamil hydrochloride has the potential for high blood pressure, heart arrhythmias and angina research .
loading...
    loading...
Art. -Nr.: HY-136250
CAS. Nr.: 2349356-09-6
Reinheit:  99.76%
Target:  

PROTACs CDK

Forschungsgebiete:  

Cancer

BSJ-03-204 is a PROTAC linking a Cereblon ligand to a CDK ligand, serving as a potent and selective dual degrader of CDK4/6. BSJ-03-204 exhibits IC50 values of 26.9 nM and 10.4 nM against CDK4/D1 and CDK6/D1, respectively. BSJ-03-204 can be utilized for cancer-related research .
loading...
    loading...
Art. -Nr.: HY-50767R
CAS. Nr.: 571190-30-2
Synonyms: PD 0332991 (Standard)
Target:  

Reference Standards CDK

Forschungsgebiete:  

Cancer

Palbociclib (Standard) is the analytical standard of Palbociclib. This product is intended for research and analytical applications. Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
Art. -Nr.: HY-179078
CAS. Nr.: 1996636-69-1
Target:  

OLIG2 Apoptosis Caspase PARP

Forschungsgebiete:  

Neurological Disease Cancer

CT-179 is a brain-penetrant and orally active OLIG2 inhibitor with a human IC50 of 1250 nM. CT-179 disrupts OLIG2 dimerization, phosphorylation, and DNA binding, blocking OLIG2-driven transcription. CT-179 induces G2/M phase arrest and increases G0 population. CT-179 induces apoptosis by reducing anti-apoptotic proteins and increasing cleaved caspase-3 and cleaved PARP. CT-179 can be used for the research of subgroup medulloblastoma .
loading...
    loading...
Art. -Nr.: HY-50767S
CAS. Nr.: 1628752-83-9
Synonyms: PD 0332991-d8
Palbociclib-d8 is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active CDK4 and CDK6 inhibitor with IC50s of 11 and 16 nM, respectively. Palbociclib has the potential for ER-positive and HER2-negative breast cancer research .
loading...
    loading...
Art. -Nr.: HY-130296
CAS. Nr.: 2366269-23-8
Reinheit:  95.23%
Synonyms: PROTAC CDK6 ligand 1
Forschungsgebiete:  

Cancer

Palbociclib-propargyl is a ligand for target protein CDK6 for PROTAC, and binds to CRBN ligand via a PEG linker to make a PROTAC CP-10. CP-10 shows a DC50 of 2.1 nM for CDK6 . Palbociclib-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Art. -Nr.: HY-50767AR
CAS. Nr.: 827022-32-2
Synonyms: PD 0332991 monohydrochloride (Standard)
Target:  

CDK Reference Standards

Forschungsgebiete:  

Cancer

Palbociclib (monohydrochloride) (Standard) is the analytical standard of Palbociclib (monohydrochloride). This product is intended for research and analytical applications. Palbociclib (PD 0332991) monohydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib monohydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
Art. -Nr.: HY-136250A
Reinheit:  99.87%
Target:  

PROTACs CDK

Forschungsgebiete:  

Cancer

BSJ-03-204 triTFA is a PROTAC connected by ligands for Cereblon and CDK. BSJ-03-204 triTFA is a potent and selective Palbociclib-based CDK4/6 dual degrader (PROTAC), with IC50s of 26.9 nM and 10.4 nM for CDK4/D1 and CDK6/D1, respectively. BSJ-03-204 triTFA does not induce IKZF1/3 degradation and has anti-cancer activity .
loading...
    loading...
Art. -Nr.: HY-176365
CAS. Nr.: 2139329-48-7
Forschungsgebiete:  

Cancer

Palbociclib-C4-Boc is a Target Protein Ligand-Linker Conjugate that incorporates a ligand for CDK4/6 Palbociclib (HY-50767) and a PROTAC linker (HY-W007803), which recruits E3 ligases. Palbociclib-C4-Boc can be used for synthesis of PROTAC BSJ-03-204 (HY-136250) .
loading...
    loading...
Art. -Nr.: HY-170851
Target:  

Apoptosis

Forschungsgebiete:  

Inflammation/Immunology Cancer

GL392 is a senolytic agent that selectively delivers the potent senolytic compound Dasatinib (HY-10181) to senescent cells. GL392 targets lipofuscin in senescent cells via the LBD domain and is linked to Dasatinib through an ester bond. Upon internalization in senescent cells, Dasatinib is released, inducing apoptosis of the senescent cells. GL392 in micelle encapsulation (mGL392) enables selective delivery to senescent cells, achieving selective senescent cell elimination in vitro and in vivo. GL392 can be used for the research of melanoma .
loading...
    loading...
Art. -Nr.: HY-I0996
CAS. Nr.: 1023594-50-4
Target:  

CDK

Forschungsgebiete:  

Cancer

1,1-Dimethylethyl 4-(4-amino-3-pyridinyl)-1-piperazinecarboxylate is the impurity of Palbociclib (HY-50767). Palbociclib is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively .
loading...
    loading...
Art. -Nr.: HY-136589
CAS. Nr.: 51012-67-0
Reinheit:  99.61%
Synonyms: NSC-609249 hydrochloride
NSC-609249 hydrochloride is an impurity of Verapamil (HY-14275). Verapamil is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor .
loading...
    loading...
Art. -Nr.: HY-50767B
CAS. Nr.: 1831842-69-3
Synonyms: PD-0332991 dihydrochloride
Target:  

CDK

Forschungsgebiete:  

Cancer

Palbociclib (PD 0332991) dihydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib dihydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
Art. -Nr.: HY-131466
CAS. Nr.: 571189-51-0
Reinheit:  99.94%
Target:  

Drug Metabolite

Forschungsgebiete:  

Others

N-Methyl Palbociclib is an impurity of Palbociclib (HY-50767). Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor.
loading...
    loading...
Art. -Nr.: HY-14275R
CAS. Nr.: 52-53-9
Synonyms: (±)-Verapamil (Standard); CP-16533-1 (Standard)
Verapamil (Standard) is the analytical standard of Verapamil. This product is intended for research and analytical applications. Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research .
loading...
    loading...